Skip to main content

Table 1 Schedule for data collection

From: The ALLEGRO trial: a placebo controlled randomised trial of intravenous lidocaine in accelerating gastrointestinal recovery after colorectal surgery

Assessment

Recruitment/baseline

POD 1

POD 2

POD 3

Daily from POD 4 until discharge

POD 7

Discharge

30 days

90 days

Assessment of eligibility criteria

        

Written informed consent

        

Pregnancy test (where applicable)

         

Demographic data, contact details

        

Clinical history/past medical history

        

Drug history esp. laxatives

        

Height

        

Weight

       

p-POSSUM

(part)

     

(part)

 

Operation type

 

       

Duration of operation

 

       

Blood loss (ml)a

 

       

OBAS score

   

QoR score

 

 

PONV score

 

    

EQ-5D-5L

 

CRPb

 

     

Time to first flatus

  

    

Time to first bowel movement

  

    

Time to tolerating solid food

  

    

antiemetic dose total up to 72 h

      

  

Total number of episodes vomiting

 

     

Total opioid consumption in-hospital up to 72 h

      

  

ERAS protocol compliance

 

     

Achievement of medical criteria for discharge Y/N

   

    

Patient-reported readiness for discharge

   

    

Length of stay (days)

      

  

Complications

      

 

Unplanned readmissions

       

 

Mortality

      

Adverse events

 

 

 

Concomitant medications

 

 
  1. aMillilitres
  2. bC-reactive protein